---
title: "A Soccer Club and a Cancer Stock Walk Into an Auto Parts Roundup"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296207236.md"
description: "Grouping Manchester United and a genomics company into an automotive suppliers list is utterly absurd. Beyond this bizarre categorization error, genuine industry players like Lear and Autoliv continue to demonstrate fundamental resilience through solid dividends and steady revenue growth in recent quarters."
datetime: "2026-08-18T09:44:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296207236.md)
  - [en](https://longbridge.com/en/news/296207236.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296207236.md)
---

# A Soccer Club and a Cancer Stock Walk Into an Auto Parts Roundup

I have seen some truly bizarre sector groupings in my time, but lumping a British football club and a cancer diagnostics firm into a "US Automotive Components" roundup? This is stupid and here's why. Someone apparently thought airbags, soccer pitches, and genome sequencing all belong in the same bucket. Good luck with that. Let's slice through this nonsense and look at what these wildly different businesses have actually been up to recently.

The only thing Manchester United (MANU.US) has in common with the auto industry is the luxury vehicles driven by its roster. Misplaced category aside, the club has been frantically trying to keep its house in order. They recently dropped their Q3 2026 earnings and decided to keep Michael Carrick on as manager this May. The stock saw a decent rebound earlier after management changes. At its core, it remains a media rights and sponsorship play, not a manufacturing one.

Then we have Veracyte (VCYT.US), another complete misfit. They are busy expanding their Decipher Prostate test availability and making strides in whole-genome MRD testing. After grabbing a spot on Forbes' 2025 list of highly successful mid-caps, the stock has maintained a solid trajectory this year. Why aren't we categorizing them in healthcare where they belong? Whoops! Someone wasn't paying attention.

Finally, the actual auto suppliers. Lear (LEA.US) is in the trenches building seats and electronic systems. They reported a solid USD 2.01 billion in revenue for Q2 2026, marking steady year-over-year growth, and swung back to profitability. Their USD 0.77 dividend is backed by actual cash flow. While the broader auto narrative is often chaotic, Lear is quietly executing.

Similarly, Autoliv (ALV.US) maintains a leading position in the automotive safety systems market. With their Q2 2026 dividend declaration of USD 0.87 per share, they are offering yields that comfortably beat the industry average. While the rest of this roundup is a masterclass in category confusion, at least the real auto parts makers are returning capital to shareholders.

_This article does not constitute investment advice._

### Related Stocks

- [MANU.US](https://longbridge.com/en/quote/MANU.US.md)
- [VCYT.US](https://longbridge.com/en/quote/VCYT.US.md)
- [LEA.US](https://longbridge.com/en/quote/LEA.US.md)
- [ALV.US](https://longbridge.com/en/quote/ALV.US.md)

## Related News & Research

- [Zacks Research Comments on Autoliv's Q4 Earnings (NYSE:ALV)](https://longbridge.com/en/news/296222872.md)
- [ABN AMRO Bank N.V. Invests $33.46 Million in Autoliv, Inc. $ALV](https://longbridge.com/en/news/296015266.md)
- [Lear posts transcript of Q2 2026 earnings call](https://longbridge.com/en/news/295457907.md)
- [Soccer-Carrick to continue as Man United head coach](https://longbridge.com/en/news/287343925.md)
- [LEA: Raised 2026 guidance after record revenue and margin gains, with strong backlog for future growth](https://longbridge.com/en/news/294535172.md)